Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention (Q43732001)

26 November 2017

Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention (English)

1 reference

26 November 2017

0 references

6

1 reference

26 November 2017

C Hiew

1

1 reference

26 November 2017

A Duggan

2

1 reference

26 November 2017

T de Malmanche

3

1 reference

26 November 2017

R Hatton

4

1 reference

26 November 2017

F Baker

5

1 reference

26 November 2017

N Collins

7

1 reference

26 November 2017

11 May 2010

1 reference

Internal Medicine Journal

26 November 2017

1 reference

26 November 2017

42

1 reference

26 November 2017

3

1 reference

26 November 2017

289-293

1 reference

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Bivalirudin during primary PCI in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Anti-platelet and anti-thrombotic approaches in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Bleeding peptic ulcer in the elderly: risk factors and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Helicobacter pylori infection in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Guidelines for prevention of NSAID-related ulcer complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

The seroepidemiology of Helicobacter pylori infection in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2010.02260.X

10.1111/J.1445-5994.2010.02260.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference